MACCARONI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.390
EU - Europa 1.423
AS - Asia 1.062
SA - Sud America 195
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 2
Totale 6.256
Nazione #
US - Stati Uniti d'America 3.305
IT - Italia 369
SG - Singapore 334
CN - Cina 241
RU - Federazione Russa 187
VN - Vietnam 169
UA - Ucraina 164
BR - Brasile 153
DE - Germania 128
SE - Svezia 116
IE - Irlanda 100
TR - Turchia 77
HK - Hong Kong 76
FI - Finlandia 68
FR - Francia 67
DK - Danimarca 63
GB - Regno Unito 61
CA - Canada 44
CI - Costa d'Avorio 42
IN - India 36
KR - Corea 33
BD - Bangladesh 31
PL - Polonia 26
MA - Marocco 23
NL - Olanda 18
AR - Argentina 16
JP - Giappone 15
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
BE - Belgio 11
EC - Ecuador 8
SC - Seychelles 7
CO - Colombia 6
IL - Israele 6
AT - Austria 5
CZ - Repubblica Ceca 5
HN - Honduras 5
PH - Filippine 5
PK - Pakistan 5
GT - Guatemala 4
IQ - Iraq 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 6.172
Città #
Ashburn 588
Chandler 272
Singapore 211
San Jose 207
Fairfield 176
Jacksonville 174
Dallas 128
Council Bluffs 104
New York 104
Dublin 99
Boardman 93
Wilmington 89
Ann Arbor 80
Woodbridge 80
Centro 74
Beijing 71
Hong Kong 71
Houston 70
Seattle 68
Los Angeles 65
Cambridge 56
Hanoi 52
Ho Chi Minh City 51
Moscow 47
Princeton 43
Abidjan 42
Munich 42
Des Moines 40
Lawrence 38
San Mateo 36
Lauterbourg 33
The Dalles 33
Turin 32
Turku 28
Orem 26
Warsaw 25
Milan 24
Chicago 23
Santa Clara 20
Ancona 19
Buffalo 19
Rome 19
Phoenix 17
Hefei 16
San Diego 16
Atlanta 15
Helsinki 13
London 13
Montreal 13
Tokyo 13
Johannesburg 12
Brooklyn 11
Pune 11
Brussels 10
São Paulo 10
Amsterdam 8
Chennai 8
Miano 8
Palermo 8
Poplar 8
Salt Lake City 8
Da Nang 7
Washington 7
Cagliari 6
Canicattì 6
Elk Grove Village 6
Florence 6
Manchester 6
Mexico City 6
Rio de Janeiro 6
South Pasadena 6
Stockholm 6
Boston 5
Denver 5
Falconara Marittima 5
Guangzhou 5
Jiaxing 5
Marche 5
Naples 5
New Delhi 5
Olomouc 5
Paris 5
Tampa 5
Wuxi 5
Bari 4
Brasília 4
Columbus 4
Curitiba 4
Frankfurt am Main 4
Haiphong 4
Modena 4
Mumbai 4
New Bedfont 4
Shanghai 4
Sterling 4
Thái Nguyên 4
Toronto 4
Vienna 4
Wuhan 4
Amman 3
Totale 3.981
Nome #
Caratterizzazione istologica e molecolare nelle pazienti con carcinoma ovarico sporadico ed ereditario 231
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 229
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 208
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 208
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 207
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 201
Optimal management of resected gastric cancer 197
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 195
5-Fluorouracil pharmacogenomics: still rocking after all these years? 182
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 182
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 178
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 177
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 177
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 175
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 172
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 170
Adjuvant treatment after surgical resection 165
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 164
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 159
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 154
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 150
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 150
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 150
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 148
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2. 146
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 144
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 144
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 144
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 143
New Insights into Hormonal Therapies in Uterine Sarcomas 143
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 141
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 134
Transient sunitinib resistance in gastrointestinal stromal tumors. 134
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1. 117
Locally advanced rectal cancer: new findings in anticancer therapy 115
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 113
Thymic epithelial tumors (TETs) and additional tumors: a single Centre experience 108
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 103
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 98
Totale 6.256
Categoria #
all - tutte 28.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022204 0 0 0 0 1 15 17 23 16 43 22 67
2022/2023744 53 99 54 57 53 106 1 49 160 6 89 17
2023/2024405 60 10 29 47 54 115 4 13 1 8 7 57
2024/2025753 107 60 14 14 48 24 88 31 112 53 111 91
2025/20262.280 211 131 142 239 322 166 351 200 168 188 61 101
2026/2027412 71 56 70 183 32 0 0 0 0 0 0 0
Totale 6.256